4d Molecular Therapeutics, Inc. · NASDAQ:FDMT
Ra Capital Management, L.P. reported a 9.90% stake in 4d Molecular Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
Ra Capital Management, L.P. reported a 9.90% stake in 4d Molecular Therapeutics, Inc., 5,713,852 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 9.90%
- Shares
- 5,713,852
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| RA Capital Management, L.P. | 9.90% | 5,713,852 |
| Peter Kolchinsky | 9.90% | 5,713,852 |
| Rajeev Shah | 9.90% | 5,713,852 |
| RA Capital Healthcare Fund, L.P. | 9.90% | 5,713,852 |
Source
Related
- 4d Molecular Therapeutics, Inc.
- Ra Capital Management, L.P.
- 4d Molecular Therapeutics, Inc. shareholders
- Schedule 13G/A · Ra Capital Management, L.P. · May 15, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Feb 14, 2025
- Form 4 · Bizily Scott · Oct 20, 2026
- Form 4 · Kirn David · Oct 7, 2026
- Form 4 · Bizily Scott · Sep 22, 2026
- Form 4 · Kirn David · Sep 16, 2026
- Form 4 · Bizily Scott · Sep 3, 2026